Royal Sense Ltd

🚀 Royal Sense Ltd Launches 17 New Pharma Products, Enters Key Health Markets

- Launched 17 new pharmaceutical products on April 27, 2026, for the domestic market.

- Products include New Cholecacirol Nano Shot (Vitamin D3 oral solution), Stergivita Caps & Syrup (multivitamins), Lycoseven Caps & Syrup (antioxidants), Dermagic KT 5 & KT 5+1 (topical creams), and Shakti-branded tonics for liver, women's health, digestion, brain health, and detox.

- New Cholecacirol Nano Shot uses nano-technology for fast absorption, contains 60,000 IU Vitamin D3 per 5ml shot, is sugar-free, and available in gulab khas/mango flavors.

- Entered Vitamin D3 segment estimated at ₹800-1,200 crore annually, growing at 8-12% CAGR.

- Entered nutraceutical market valued at ₹50,000-60,000 crore, growing at 15-20% CAGR.

- Dermagic KT 5 and KT 5+1 target dermatology market worth ₹20,000-25,000 crore with triple-action formulations for fungal/bacterial infections.

- Shakti-branded products address liver tonic segment (₹2,000-3,500 crore) and women's health segment (₹4,000-6,000 crore).

- Products cater to specific audiences: children, adults, elderly, and those with lifestyle-related health issues, with dosages tailored per product.